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Gender -related dissociation in outcomes in chronic heart failure in
Moroccan woman: clinical, biological and echocardiographic features
Ghizlane Abidi, Imad Nouamou, Fz Sabri, Rachida Habbal
CHU Ibn Rochd, Cardiologie, Casablanca, Maroc
Introduction: Chronic heart failure (CHF) is a major cause of morbidity
and mortality in the world. Few studies have examined the difference between
the two gender and features in African woman.
Methods: We conducted a retrospective study of patients with chronic
heart failure followed between 2006- 2012 at the daily hospital Ibn Rochd in
Casablanca. Of the 1613 patients, 603 were women. We studied the preva-
lence of cardiovascular risk factors, the severity of clinical symptoms and
major cardiovascular events (acute coronary syndrom, stroke and acute heart
failure). We also collected biological parameters (serum sodium, serum potas-
sium, hemoglobin and creatinine) and echocardiographic criteria with poor
prognosis (dilated left ventricular>60mm, ejection fraction<35%, pulmonary
hypertension, severe mitral regurgitation). We compared our results with sta-
tistical analysis to the men of our population to identify prognostic markers in
women with CHF.
Results: Mean age was 68,3 years. Woman is more likely to hypertension
(49% vs 33%) and diabetes (39% vs 27%). Smoking is less common in
women (with 3.4% vs 48%). Further, metabolic disorder dominates in the
male population specially anemia. There is no significant difference in the
severity of clinical symptoms. The etiology of CHF is dominated in women
by valvulopathy, but man ischemic etiology dominates as in the developed
countries. For echocardiographic features, half women has ejection fraction
less than 35%. In addition, pulmonary arterial hypertension beyond 40 mmHg
was significantly elevated in women. We find a higher acute cardiac decom-
pensation rate at 9.9% vs. 7.7% (p = 0.01). Otherwise, the occurrence of major
cardiovascular events is lower in women such as myocardial infraction (29%
vs 40.3%) and stroke (5.9% vs 19%) p<0,001. 
Conclusion: Moroccan woman with chronic heart failure is more predis-
posed to cardiovascular risk factors and acute heart decompensation. Never-
theless, she has fewer major cardiovascular events.
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Risk factors for the occurrence of chronic renal failure in the chronic
heart failure
Salim Arous, Amina Asadi, Karim Hafdi, Hayat Najih, Rachida Habbal
CHU Ibn Rochd, Cardiologie, Casablanca, Maroc
Introduction: Renal failure is common in patients with chronic heart
failure, with a prevalence ranging from 20 % to 57%, and a poor prognosis
and a high risk of readmission. No study had specifically studied the risk fac-
tors for the development of renal dysfunction in chronic heart failure. The aim
of our study was to determine predictive factors of progression to chronic
renal failure in patients treated for chronic heart failure.
Methods: We conducted a prospective study on 563 patients with chronic
heart failure during a period of 2 years between July 30, 2012 and July 30,
2014.
Results: Among the proportion studied, 262 patients (46.5 %) had devel-
oped a renal failure. The risk factors of the onset of renal failure in chronic
heart failure were: age above 60 years (p < 0.0001), diabetes (p < 0.0001),
hypertension (p < 0.0001), an ejection fraction less than 35% (p < 0.0001), a
low deceleration time of mitral flow (p<0.0001), pulmonary hypertension
(p<0.0001), anemia and hyperuricemia (p<0.0001).
Conclusion: The interaction between the heart and kidneys among patients
with heart failure is a complex relationship. A complete understanding of the
bidirectional interactions between the two organs remains elusive.
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Influence of dyslipidemia on clinical characteristics in heart failure
patients. Series of 583 cases
Fatima Arhlade, Amina Asadi, Safaa Raboukhi, Rachida Habbal
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Background and Aims: Dyslipidemia is a high risk factor of heart
disease. Among heart disease, the prevalence of heart failure is increasing in
recent years. We aim to investigate the association between lipid profile and
age, gender, clinical and echocardiographic characteristics and the influences
of dyslipidemia on heart failure.
Methods: This retrospective study including 583 patients (72 years, 338
were male) admitted in the therapeutic unit of heart failure (TUHF). All
patients underwent measurement of serum lipid profiles. They were divided
into two groups based on combining dyslipidemia or not. Clinical characteris-
tics, biochemical data and echocardiography were analyzed in both groups.
Results: There were 246 (45%) patients diagnosed with dyslipidemia in
our study. Mean serum levels of total cholesterol and triglycerides were 2.31g/l
and 2,59g/l respectively in group with dyslipidemia. Young age, diabetes,
hypertension, strock attack, and coronary heart disease were associated with
dyslipidemia (p value <0.001).Patients with dyslipidemia had a significantly
diastolic dysfonction (p=0.035) and lower functional capacity during six –
minute walk. Higher level of glucose was also noted in dyslipidemia popula-
tion. No sex-related difference in dyslipidemia and nondyslipidemia (p=0.17)
and no correlation between dyslipidemia and cardiac decompensation were
found (p=0.36).
Conclusions: Dyslipidemia is associated with others risk factors of coro-
nary heart disease. These results demonstrate a correlation between functional
capacity, left ventricular diastolic dysfunction and dyslipidemia.
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Background: Heart failure (HF) has become a major epidemic and a sig-
nificant public health problem, with considerable morbidity and mortality.
Uric acid (UA) levels are frequently increased in patients with heart failure
(HF), and may be an indicator of a poor prognosis and an innovative target for
treatment. We evaluated the prognostic effect of UA on clinical outcome in
patients with HF. In addition, we looked at the relation of UA to echocardio-
graphic parameters in a subset of these patients.
Methods and Results: Totally 309 consecutive patients with chronic
heart failure symptomatic class II, III, or IV were retrospectively studied.
Clinical, electrocardiographic, echocardiographic and biological data were
investigated. 84% of the patients had elevated UA (>70mg/L in men and
>60mg/l in women). We divided patients on 2 groups: group 1 with hyper-
uricemia and group 2 without hyperuricemia. Mean UA levels were 71,4mg/l
in group 1 and 42,2mg/l in group 2. Male sex, diabetes mellitus, hyperlipi-
demia, and ischemic heart disease were associated with higher UA levels.
Increased urea and creatinine were also associated with higher UA levels,
whereas reduced estimated glomerular filtration rate, hyponatremia treat-
ment with furosemide were seen with higher UA levels. An increase in UA
levels was a predictor of increased cardiac hospitalizations (p= 0.0001) and
mortality (p<0.00039). Echocardiographic data demonstrated a significant
correlation between UA levels and E/A ratio, a marker of diastolic dysfunc-
tion (p<0.0001).
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